Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
Go back to Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma| Rider Explorations, Inc. (NASDAQ: REPL) | Delayed: 9.70 -0.76 (7.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.46 | 52 Week High | $1.45 | |||
| Open | $10.30 | 52 Week Low | $0.50 | |||
| Day High | $10.38 | P/E | N/A | |||
| Day Low | $9.65 | EPS | $0.00 | |||
| Volume | 3,267,051 | |||||
